Evidence for a bone-kidney axis regulating phosphate homeostasis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Investigation

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI19687PMID 12952909PMCID PMC182218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.

  2003cited by this paper
• Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.

  2003cited by this paper
• Evidence for the Proteolytic Processing of Dentin Matrix Protein 1

  2003cited by this paper
• Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX*

  2003cited by this paper
• Targeted Disruption of the Osteoblast/Osteocyte Factor 45 Gene (OF45) Results in Increased Bone Formation and Bone Mass*

  2003cited by this paper
• Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis

  2003cited by this paper
• Human Fibroblast Growth Factor-23 Mutants Suppress Na+-dependent Phosphate Co-transport Activity and 1α,25-Dihydroxyvitamin D3 Production*

  2003cited by this paper
• A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.

  2002cited by this paper
• Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

  2002cited by this paper
• Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism

  2002cited by this paper
• Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

  2002cited by this paper
• Dietary Essential Amino Acid Supplements Increase Bone Strength by Influencing Bone Mass and Bone Microarchitecture in Ovariectomized Adult Rats Fed an Isocaloric Low‐Protein Diet

  2002cited by this paper
• New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia

  2002cited by this paper
• Fibroblast Growth Factor (FGF)-23 Inhibits Renal Phosphate Reabsorption by Activation of the Mitogen-activated Protein Kinase Pathway*

  2002cited by this paper
• High bone density due to a mutation in LDL-receptor-related protein 5.

  2002cited by this paper
• Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

  2002cited by this paper
• Inhibition of MEPE cleavage by Phex.

  2002cited by this paper
• Hypophosphatemic rickets accompanying McCune–Albright syndrome: evidence that a humoral factor causes hypophosphatemia

  2001cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

  2001cited by this paper
• Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem.

  2001cited by this paper
• Current topics on cytapheresis technologies.

  2001cited by this paper
• Renal Phosphate Wasting in Fibrous Dysplasia of Bone Is Part of a Generalized Renal Tubular Dysfunction Similar to That Seen in Tumor‐Induced Osteomalacia

  2001cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Identification of Osteoblast/Osteocyte Factor 45 (OF45), a Bone-specific cDNA Encoding an RGD-containing Protein That Is Highly Expressed in Osteoblasts and Osteocytes*

  2000cited by this paper
• MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.

  2000cited by this paper
• Coordinated Maturational Regulation of PHEX and Renal Phosphate Transport Inhibitory Activity: Evidence for the Pathophysiological Role of PHEX in X‐Linked Hypophosphatemia

  1999cited by this paper
• Posttranscriptional regulation of the proximal tubule NaPi-II transporter in response to PTH and dietary Pi.

  1999cited by this paper
• Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.

  1998cited by this paper
• Intrinsic mineralization defect in Hyp mouse osteoblasts.

  1998cited by this paper
• Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets.

  1997cited by this paper
• A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets

  1995cited by this paper
• Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men.

  1989cited by this paper
• Interactions between vitamin D deficiency and phosphorus depletion in the rat.

  1979cited by this paper
• Inorganic phosphate homeostasis. Renal adaptation to the dietary intake in intact and thyroparathyroidectomized rats.

  1976cited by this paper

• FGF-based drug discovery: advances and challenges

  2025cites this paper
• Differential Serum Phosphate Levels in Pediatric Febrile Syndromes and Their Clinical Significance

  2024influential citation
• Phosphorus: Chronicles of the epistemology of a vital element.

  2024cites this paper
• Circulating α-Klotho counteracts TGF-β-induced sarcopenia.

  2023cites this paper
• Uncovering genetic causes of hypophosphatemia

  2023cites this paper
• Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice

  2022cites this paper
• Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice S

  2022influential citation
• Identification of Small-Molecule Inhibitors of Fibroblast Growth Factor 23 Signaling via In Silico Hot Spot Prediction and Molecular Docking to α-Klotho

  2022cites this paper
• FGF23—an established master regulator of phosphate metabolism

  2021cites this paper
• The Saga of Endocrine FGFs

  2021cites this paper
• Higher Fibroblast Growth Factor 23 Levels Are Causally Associated With Lower Bone Mineral Density of Heel and Femoral Neck: Evidence From Two-Sample Mendelian Randomization Analysis

  2020cites this paper
• Small molecule FGF23 inhibitors increase serum phosphate and improve skeletal abnormalities in Hyp mice

  2020cites this paper
• Design and development of FGF-23 antagonists: Definition of the pharmacophore and initial structure-activity relationships probed by synthetic analogues.

  2020cites this paper
• Linear and Non-linear Correlations Between Serum Phosphate Level and Bone Mineral Density in Type 2 Diabetes

  2020cites this paper
• Fibroblast growth factor 23 and its role in phosphate homeostasis in growing children compared to adults

  2020cites this paper
• Identification of Small-Molecule Inhibitors of FGF23 Signaling via In Silico Hot Spot Prediction and Molecular Docking to α-Klotho

  2020cites this paper
• Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders

  2019cites this paper
• Impact of Serum Fibroblast Growth Factor-23 & Undercaboxylated Osteocalcin Levels on Carotid Artery Calcification among Type2 Diabetics

  2019cites this paper
• ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors—A STING in the Tale of ENPP1

  2019cites this paper
• Fibroblast growth factor 23 and &agr;-Klotho co-dependent and independent functions

  2019cites this paper
• Fibroblast Growth Factor 23 as a Therapeutic Target

  2018cites this paper
• Role of Fibroblast Growth Factor-23 in Innate Immune Responses

  2018cites this paper
• Osteomalacia, renal Fanconi syndrome, and bone tumor

  2018cites this paper
• FGF-23 Counter-Regulatory Hormone for Vitamin D Actions on Mineral Metabolism, Hemodynamics, and Innate Immunity

  2018cites this paper
• Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions

  2017cites this paper
• Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.

  2017cites this paper
• Dietary capsaicin and antibiotics act synergistically to reduce non-alcoholic fatty liver disease induced by high fat diet in mice

  2017cites this paper
• 18 Monogenic Phosphate Balance Disorders

  2017cites this paper
• Effect of Osteocyte-Ablation on Inorganic Phosphate Metabolism: Analysis of Bone–Kidney–Gut Axis

  2017cites this paper
• Chronological immunolocalization of sclerostin and FGF23 in the mouse metaphyseal trabecular and cortical bone.

  2017cites this paper
• Reports of 17 Chinese patients with tumor-induced osteomalacia

  2017cites this paper
• Immunolocalization of osteocyte-derived molecules during bone fracture healing of mouse ribs.

  2016cites this paper
• A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia

  2016cites this paper
• Multiple faces of fibroblast growth factor-23

  2016cites this paper
• Counter‐regulatory paracrine actions of FGF‐23 and 1,25(OH)2D in macrophages

  2016cites this paper
• Frequency of Teriparatide Administration Affects the Histological Pattern of Bone Formation in Young Adult Male Mice.

  2016cites this paper
• Conditional Deletion of Fgfr1 in the Proximal and Distal Tubule Identifies Distinct Roles in Phosphate and Calcium Transport

  2016cites this paper
• Bone Disease in Thalassemia: A Molecular and Clinical Overview.

  2016cites this paper
• Enfermedad óseo-mineral en la enfermedad renal crónica. Implicaciones en el riesgo cardiovascular

  2016cites this paper
• FGF23 gene variation and its association with phosphate homeostasis and bone mineral density in Finnish children and adolescents.

  2015cites this paper
• The Vestibular System: A Newly Identified Regulator of Bone Homeostasis Acting Through the Sympathetic Nervous System

  2015cites this paper
• Hyperphosphaturic Mesenchymal Tumor induced Osteomalacia– A Case Report

  2015cites this paper
• Hypophosphatemic rickets: etiology, clinical features and treatment

  2015cites this paper
• Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis: Case report and literature review

  2015cites this paper
• The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment

  2014cites this paper
• Lanthanum carbonate stimulates bone formation in a rat model of renal insufficiency with low bone turnover

  2014cites this paper
• Four Cases of X-Linked Hypophosphatemic Rickets, Clinical Description and Genetic Testing

  2014influential citation
• A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease.

  2013cites this paper
• Calcium regulates FGF-23 expression in bone.

  2013cites this paper
• Ultraviolet B activated 1,25(OH)(2)D affects the level of fibroblast growth factor-23 in human.

  2013cites this paper
• Management of Calcium and Bone Disease in Renal Patients

  2013cites this paper
• Persistent Low Level of Osterix Accelerates Interleukin-6 Production and Impairs Regeneration after Tissue Injury

  2013cites this paper
• Phosphatonins: physiological role and pathological changes.

  2012cites this paper
• Mise en place du dosage de la PTH 1-84 avec l'automate liaison XL dans le cadre de l'accréditation selon la norme NF en ISO 15189

  2012cites this paper
• Regulation and function of the FGF23/klotho endocrine pathways.

  2012cites this paper
• Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism

  2012cites this paper
• The distribution of osteocytic lacunar–canalicular system, and immunolocalization of FGF23 and sclerostin in osteocytes

  2012cites this paper
• Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.

  2012cites this paper
• FGF23/Klotho New Regulators of Vitamin D Metabolism

  2011cites this paper
• Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.

  2011cites this paper
• Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.

  2011cites this paper
• Monogenic Phosphate Balance Disorders

  2011cites this paper
• rescues the Hyp mouse phenotype Compound deletion of Fgfr3 and Fgfr4 partially

  2011cites this paper
• Genetics and epidemiology of ectopic calcification.

  2011cites this paper
• ASARM Mineralization Hypothesis: A Bridge Too Far?

  2010cites this paper
• Oncogenic osteomalacia: Problems in diagnosis and long-term management

  2010cites this paper
• A synopsis of phosphate disorders in the nursing home.

  2010cites this paper
• Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts

  2010cites this paper
• Cinin hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review

  2010cites this paper
• Metabolic and Endocrine Disorders of the Skeleton

  2010cites this paper
• Regulation of phosphate transport in proximal tubules

  2009influential citation
• Effects of hPTH(1‐34) Infusion on Circulating Serum Phosphate, 1,25‐Dihydroxyvitamin D, and FGF23 Levels in Healthy Men

  2009influential citation
• Role of the small integrin-binding ligand N-linked glycoprotein (SIBLING), bone sialoprotein (BSP) in bone development and remodeling

  2009cites this paper
• FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling.

  2009cites this paper
• Nuclear Isoforms of Fibroblast Growth Factor 2 Are Novel Inducers of Hypophosphatemia via Modulation of FGF23 and KLOTHO*

  2009cites this paper
• Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

  2009cites this paper
• Genetic Defects in Renal Phosphate Handling

  2009cites this paper
• FISIOPATOLOGIA DELL'IPERPARATIROIDISMO SECONDARIO: RUOLO DI FGF23 E KLOTHO

  2009cites this paper
• Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients.

  2008cites this paper
• CHAPTER 94 – Management of Calcium and Bone Disease in Renal Patients

  2008cites this paper
• Pathogenic role of Fgf23 in Dmp1-null mice.

  2008cites this paper
• A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet.

  2008cites this paper
• Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

  2008cites this paper
• Regulation of bone remodeling by the central and peripheral nervous system.

  2008cites this paper
• Occult nasal sinus tumours causing oncogenic osteomalacia.

  2008cites this paper
• Molecular Genetics of Inherited Hypophosphataemias

  2008cites this paper
• Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.

  2008cites this paper
• Pathogenic role of Fgf 23 in Dmp 1-null mice

  2008cites this paper
• Correlation among Hyperphosphatemia, Type II Sodium–Phosphate Transporter Activity, and Vitamin D Metabolism in Fgf‐23 Null Mice

  2007cites this paper
• Hepatic surgery-related hypophosphatemia.

  2007cites this paper
• "EFECTO DE LA LECHE DE CABRA O VACA, ENRIQUECIDA O NO EN CALCIO, SOBRE LA BIODISPONIBILIDAD DE HIERRO, CALCIO, FÓSFORO Y MAGNESIO EN SITUACIÓN DE ANEMIA FERROPÉNICA NUTRICIONAL"

  2007cites this paper
• Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.

  2007cites this paper
• Hypophosphatemic Rickets in Opsismodysplasia

  2007cites this paper
• More on the bone-kidney axis--lessons from hypophosphataemia.

  2007cites this paper
• Fisiopatologia del metabolismo calcio fosforo: Patogenesi dell'iperparatiroidismo secondario: nuove acquisizioni

  2007cites this paper
• Osteoblast Autonomous Pi Regulation via Pit1 Plays a Role in Bone Mineralization

  2007cites this paper
• How fibroblast growth factor 23 works.

  2007cites this paper
• A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.

  2007cites this paper
• Mineralized tissue cells are a principal source of FGF23.

  2007cites this paper
• Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia

  2006cites this paper